Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-08-22

Clinical Trial Update: MR-targeted vs. Random TRUS-guided Prostate Biopsy [NA]

View source ↗

Summary

An update on an ongoing trial comparing MR-targeted prostate biopsy with random TRUS-guided biopsy for detecting prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fondazione del Piemonte per l'Oncologia | Conditions: Prostate Cancer | NA | Status: UNKNOWN